Progesterone Shots vs Suppositories
Plain-language summary: A clinic-directed guide to progesterone shots versus suppositories in FET or luteal support, including route-specific evidence, monitoring questions, side effects, and missed-dose planning.
Educational boundary: this article is for general education only. It does not diagnose infertility, confirm ovulation, prescribe treatment, give individualized dosing, or promise pregnancy outcomes. Review personal decisions with a qualified clinician.
Early answer
Progesterone route in a frozen embryo transfer or luteal-support plan is clinic-directed. Shots and suppositories can differ by cycle type, lab interpretation, side effects, access, and protocol, so do not switch or combine routes without the treating clinic.
Common questions this guide answers
- Are progesterone shots and suppositories interchangeable in FET?
- What should I ask before changing progesterone route?
- What if I miss a dose or my progesterone lab looks low?
These questions can depend on age, cycle pattern, medications, partner factors, and medical history. This topic can affect medical decisions, treatment timing, pregnancy safety, or emotional distress. Use it to prepare questions for a qualified clinician, not to self-diagnose or self-treat.
What the sources support
This draft is anchored to CDC: ART Success Rates, SART: Success Rates, ASRM: Fertility Evaluation of Infertile Women, PubMed: Intramuscular Progesterone Optimizes Live Birth From Programmed FET, Fertility and Sterility Reports: Progesterone in Frozen Embryo Transfer Cycles. The sources support broad concepts, not a personal care plan:
- CDC: ART Success Rates - Supports U.S. ART success-rate context and clinic data caveats.
- SART: Success Rates - Supports ART success-rate interpretation without outcome guarantees.
- ASRM: Fertility Evaluation of Infertile Women - Supports evaluation topics such as ovulation, tubal, uterine, semen, and ovarian-reserve factors.
- PubMed: Intramuscular Progesterone Optimizes Live Birth From Programmed FET - Supports route-specific progesterone evidence in programmed frozen embryo transfer cycles and cautions against assuming every route is interchangeable.
- Fertility and Sterility Reports: Progesterone in Frozen Embryo Transfer Cycles - Supports progesterone route, assay, and medicated FET context for clinic-directed decisions.
Why progesterone route matters
- Progesterone support can be part of programmed frozen embryo transfer, modified or natural FET, IUI, or other luteal-support plans, and route decisions are not one-size-fits-all.
- Route-specific FET evidence and reviews discuss intramuscular, vaginal, and combined approaches, but they still need clinic interpretation for the exact protocol.
- Serum progesterone timing, assay limits, side effects, access, cost, and adherence can all change how the clinic interprets a route or lab result.
Questions before changing anything
- Ask which route and product are intended, what time doses are due, what to do after a missed or late dose, and who can approve a substitute.
- Ask whether progesterone blood tests are used in this protocol and how results are interpreted for shots, vaginal products, or combined support.
- Ask what bleeding, pain, allergic reaction, injection-site problem, severe symptom, or medication access issue should prompt a same-day clinic call.
Progesterone route review table
Use this table for clinic questions. It is not a dosing plan and it should not be used to switch products.
| Question | Why it matters |
|---|---|
| What cycle type is this? | Programmed FET, natural or modified FET, IUI, and other luteal-support plans can use progesterone differently. |
| Which route and product are intended? | Intramuscular shots, vaginal suppositories, inserts, gels, and combined plans are not automatically interchangeable. |
| Are labs being monitored? | Serum progesterone timing and interpretation can vary by route, assay, clinic threshold, and transfer plan. |
| What side effects or access issues matter? | Injection-site reactions, vaginal irritation, cost, supply, travel, and missed-dose risk can change the practical plan. |
| Who approves changes? | Substitutions, missed doses, low lab results, bleeding, or severe symptoms should go through the treating clinic's contact plan. |
When to talk to a clinician
Talk to a clinician or fertility specialist when:
- you are younger than 35 and have been trying for about 12 months without pregnancy;
- you are 35 or older and have been trying for about 6 months without pregnancy;
- you are over 40, have irregular or absent periods, known PCOS or endometriosis, prior pelvic infection or surgery, repeated pregnancy loss, cancer-treatment timing, or another known fertility risk;
- you have severe pain, heavy bleeding, fainting, symptoms of infection, or emotional distress that feels unsafe;
- a test result, medicine, supplement, or treatment decision would change what you do next.
Those timelines are general. A clinician can recommend earlier evaluation when history or symptoms raise concern.
Questions to bring
| Question | Why it matters |
|---|---|
| What does this topic mean for my age, cycle pattern, and history? | General fertility advice can change with age, symptoms, and prior pregnancy history. |
| Should my partner or donor path be evaluated at the same time? | Fertility factors can involve eggs, ovulation, tubes, uterus, sperm, donors, or unexplained factors. |
| Which tests would change the plan? | Testing is most useful when it answers a decision question. |
| What symptoms or results should make me call sooner? | Safety thresholds should be clear before waiting another cycle. |
How to use this guide safely
Use the article as a preparation tool, not as a decision engine. Before applying the information, write down what you know and what remains uncertain:
- your age and how long you have been trying;
- usual cycle length, skipped periods, heavy bleeding, severe pain, or symptoms that do not fit your usual pattern;
- current prescription medicines, over-the-counter medicines, supplements, and any medication changes being considered;
- prior pregnancy, miscarriage, ectopic pregnancy, pelvic infection, surgery, cancer treatment, or fertility-treatment history;
- partner semen-analysis history, donor plans, or LGBTQ+ family-building needs that may change the evaluation route.
Bring that list to a clinician, fertility clinic, pharmacist, or counselor as appropriate. A source-backed article can make the conversation more focused, but it cannot weigh your personal risks, interpret all test results, or choose between monitoring, expectant management, medication, IUI, IVF, donor options, or other care paths.
Related internal guides
- When to Seek Fertility Help
- Pregnancy After 35: Preconception Questions
- Genetic Carrier Screening Before Pregnancy
- Partner Health and Fertility Planning
FAQ
Are progesterone shots and suppositories interchangeable in FET?
Progesterone shots and vaginal progesterone are not automatically interchangeable in every frozen embryo transfer plan. Route, dose, cycle type, lab monitoring, side effects, and clinic protocol need the treating clinic interpretation.
What should I ask before changing progesterone route?
Do not switch routes, combine products, or stop progesterone from a general article. Ask the clinic which route is intended, how labs are interpreted, what side effects matter, and who confirms any substitution in writing.
What if I miss a dose or my progesterone lab looks low?
Missed doses, late doses, bleeding, new severe symptoms, or a progesterone result that worries you should be handled through the clinic contact plan. Ask whether there is a rescue instruction and what result would change the schedule.
Authoritative sources
- CDC: ART Success Rates - Supports U.S. ART success-rate context and clinic data caveats.
- SART: Success Rates - Supports ART success-rate interpretation without outcome guarantees.
- ASRM: Fertility Evaluation of Infertile Women - Supports evaluation topics such as ovulation, tubal, uterine, semen, and ovarian-reserve factors.
- PubMed: Intramuscular Progesterone Optimizes Live Birth From Programmed FET - Supports route-specific progesterone evidence in programmed frozen embryo transfer cycles and cautions against assuming every route is interchangeable.
- Fertility and Sterility Reports: Progesterone in Frozen Embryo Transfer Cycles - Supports progesterone route, assay, and medicated FET context for clinic-directed decisions.